Aerocort Hfa 100 Mcg/50 Mcg Inhaler

Aerocort Hfa Inhaler (Levosalbutamol 50 mcg & Beclometasone Dipropionate 50 mcg) is a high-performance combination respiratory therapy manufactured by Cipla Limited. Engineered for the synergistic management of asthma and Chronic Obstructive Pulmonary Disease (COPD), Aerocort Hfa provides both rapid-acting bronchodilation and intensive anti-inflammatory protection. Utilizing a modern, ozone-friendly Hydrofluoroalkane (HFA) propellant system, this inhaler ensures consistent and precise delivery of medication directly into the deep lung tissues.

1. Manufacturer Profile: Cipla Limited

Cipla is a global pioneer in respiratory medicine, recognized for making high-quality inhalation therapies accessible worldwide through its world-class R&D hubs.

• Regulatory Standing: Produced in US FDA and WHO-GMP approved facilities that specialize in aerosol technology and extrafine particle distribution.
• Inhalation Innovation: Cipla’s HFA technology provides a consistent “soft mist” delivery that is easier for patients to coordinate compared to older CFC-based inhalers.

2. Composition & Ingredients

Each metered dose (single actuation) of Aerocort Hfa contains:

• Levosalbutamol (as Sulfate): 50 mcg – The rapid-acting bronchodilator (R-isomer of Albuterol).
• Beclometasone Dipropionate IP: 50 mcg – The potent inhaled corticosteroid (ICS).
• Propellant: HFA-134a (Hydrofluoroalkane), a non-CFC, environmentally friendly aerosol agent.

3. Mechanism of Action: How It Works

Aerocort Hfa utilizes a two-pronged pharmacological strategy to restore normal lung function and prevent future attacks.

A. Rapid Bronchodilation (Levosalbutamol)

Levosalbutamol is the single active (R)-isomer of racemic salbutamol. It acts as a highly selective beta2-adrenergic agonist. By binding to these receptors in the bronchial smooth muscles, it triggers rapid relaxation and opening of the airways within 1 to 5 minutes. Because it lacks the (S)-isomer, many patients report fewer side effects like heart palpitations and tremors compared to standard albuterol.

B. Intensive Anti-Inflammatory Action (Beclometasone)

Beclometasone is an “extrafine” corticosteroid that targets the underlying inflammation of the airways. It suppresses the release of inflammatory mediators and reduces mucosal edema (swelling) within the bronchial tubes. By stabilizing the airways over time, it reduces the frequency and severity of asthma exacerbations.

4. Therapeutic Indications

Aerocort Hfa is clinically indicated for:

• Asthma Management: Regular treatment of reversible obstructive airway disease where a combination of a bronchodilator and an inhaled steroid is appropriate.
• COPD Symptom Relief: Providing both maintenance and symptomatic relief for patients with Chronic Obstructive Pulmonary Disease.
• Bronchospasm: Rapidly reversing the “tight chest” sensation associated with various respiratory triggers.

5. Clinical Comparison: Aerocort vs. Seretide

6. Dosing & Administration

Standard Dosing Protocol

• Adults and Children (12+): Usually one or two inhalations twice daily.
• Maintenance: Must be used regularly to maintain control over inflammation.

Step-by-Step Usage Instructions

1. Wash hands and remove the mouthpiece cap.
2. Shake the inhaler well for 5 seconds to mix the HFA suspension.
3. Breathe out as far as is comfortable, away from the device.
4. Place the mouthpiece in the mouth and start to breathe in slowly and deeply.
5. Simultaneously press down on the canister to release a puff.
6. Hold your breath for 10 seconds to allow the medicine to settle in the lungs.
7. Rinse & Spit: Always rinse your mouth with water after use to prevent oral thrush.

7. Precautions & Safety Warnings

• Cardiovascular: Use with caution in patients with heart disease, high blood pressure, or hyperthyroidism.
• Not for Acute Relief Alone: While Aerocort acts fast, it contains a steroid. Do not use it as your ONLY rescue inhaler if your doctor has provided a separate SABA for emergencies.
• Oral Hygiene: Mandatory “rinse and spit” is required to prevent hoarseness and localized fungal infections.

8. Well-Researched FAQs

Q: Is Aerocort the same as a rescue inhaler?

A: It contains a rescue component (Levosalbutamol), but because it also contains a steroid, it is primarily a “maintenance” inhaler that must be used regularly.

Q: Why is my Aerocort Hfa purple?

A: This is a standard Cipla branding color for the Aerocort range, helping patients distinguish it from other inhalers like Asthalin (blue) or Foracort (red).

Q: How many doses are in one inhaler?

A: The standard Aerocort Hfa canister provides 200 metered actuations. Most devices feature a dose counter to track usage.

9. Official Regulatory References

1. Cipla Respiratory Portfolio: Official Product Database
2. Global Initiative for Asthma (GINA): 2026 Guidelines for Combination Therapy.

Medical Disclaimer: This content is AI-generated for educational purposes based on clinical pharmaceutical data. It is NOT medical advice. Always consult a licensed healthcare professional for diagnosis and treatment.